In a patient with glomerular hematuria, proteinuria, and declining estimated glomerular filtration rate, how do lupus nephritis, IgA nephropathy, and ANCA‑associated pauci‑immune glomerulonephritis differ in their pathophysiology?

Pathophysiologic Differentiation of Lupus Nephritis, IgA Nephropathy, and ANCA-Associated Pauci-Immune Glomerulonephritis

These three glomerulonephritides are distinguished fundamentally by their immune mechanisms: lupus nephritis is driven by immune complex deposition in the setting of systemic autoimmunity with complement activation, IgA nephropathy results from mesangial deposition of galactose-deficient IgA1-containing immune complexes, and ANCA-associated pauci-immune glomerulonephritis is mediated by neutrophil activation and direct endothelial injury with minimal or absent immune complex deposition. 1, 2

Lupus Nephritis: Immune Complex-Mediated Systemic Autoimmune Disease

Core Pathogenic Mechanism

• Immune complex formation and deposition occurs when circulating autoantibodies (anti-dsDNA, anti-nucleosome, anti-C1q) bind nuclear antigens, forming complexes that deposit in glomerular mesangium, subendothelial, and subepithelial spaces 1

• Complement activation is central to tissue injury, with consumption of C3 and C4 leading to low serum complement levels—a hallmark serologic finding that distinguishes lupus nephritis from the other two entities 1, 2

• "Full-house" immunofluorescence pattern demonstrates simultaneous deposition of IgG, IgA, IgM, C3, and characteristically C1q in mesangial and capillary wall distributions 1, 2

Histopathologic Features

• Subendothelial immune deposits are the pathognomonic feature of proliferative lupus nephritis (Classes III and IV), visible on electron microscopy and sometimes identifiable by light microscopy as "wire-loop" lesions 1

• Variable patterns of injury range from minimal mesangial (Class I) to diffuse proliferative (Class IV) to membranous (Class V), reflecting the heterogeneity of immune complex deposition sites and inflammatory responses 1

• Tubulointerstitial and vascular involvement frequently accompanies glomerular disease, with lupus vasculopathy defined as luminal narrowing by intramural immune deposits without vessel wall inflammation 1

Clinical Context

• Lupus nephritis occurs in the setting of systemic lupus erythematosus with multiorgan involvement, positive ANA, anti-dsDNA antibodies, and low complement levels 1, 2

• The disease affects predominantly young women and shows higher incidence in Asian, African/Caribbean, and Hispanic populations 1

IgA Nephropathy: Mesangial Immune Complex Disease

Core Pathogenic Mechanism

• Galactose-deficient IgA1 (Gd-IgA1) is produced due to aberrant O-glycosylation, leading to formation of circulating immune complexes containing IgA1 and anti-Gd-IgA1 antibodies 3

• Mesangial deposition of these IgA-containing immune complexes triggers mesangial cell proliferation, matrix expansion, and inflammatory mediator release 3, 4

• Complement activation via the alternative pathway contributes to glomerular injury, but C3 and C4 levels remain normal in serum—a key distinction from lupus nephritis 3

Histopathologic Features

• Mesangial-dominant or co-dominant IgA deposits on immunofluorescence are the defining diagnostic criterion, distinguishing IgA nephropathy from all other glomerulonephritides 1, 2

• Mesangial electron-dense deposits on electron microscopy correspond to the IgA-containing immune complexes 1

• Variable glomerular injury patterns include mesangial proliferation, endocapillary hypercellularity, segmental sclerosis, and crescents, graded by the Oxford MEST-C classification 1, 3

Clinical Context

• IgA nephropathy is the most common immune-mediated glomerular disease worldwide, with highest incidence in East Asia 3

• Synpharyngitic hematuria (gross hematuria concurrent with upper respiratory infection) occurs in up to 30% of patients and is highly characteristic 3, 4

• The disease typically presents in younger adults (mean age 34-45 years) with isolated hematuria and proteinuria, without systemic autoimmune features 3

ANCA-Associated Pauci-Immune Glomerulonephritis: Neutrophil-Mediated Direct Injury

Core Pathogenic Mechanism

• ANCA antibodies (directed against myeloperoxidase [MPO] or proteinase 3 [PR3]) activate primed neutrophils, causing degranulation and respiratory burst at the endothelial surface 1, 2

• Direct endothelial injury and necrosis result from neutrophil-mediated oxidative damage and protease release, leading to fibrinoid necrosis and glomerular basement membrane rupture 1

• Absence of immune complex deposition is the defining pathophysiologic feature—hence "pauci-immune"—with 80-90% of cases having positive ANCA serology 1, 2

Histopathologic Features

• Negative or minimal immunoglobulin staining (<1-2+) on immunofluorescence distinguishes pauci-immune disease from immune complex-mediated glomerulonephritides; fibrinogen may be present in necrotic areas 1, 2

• Necrotizing and crescentic pattern with segmental or global fibrinoid necrosis, glomerular basement membrane rupture, and cellular or fibrocellular crescents characterizes active disease 1

• Absence of electron-dense deposits on electron microscopy confirms the pauci-immune nature and excludes immune complex disease 2

Clinical Context

• ANCA-associated glomerulonephritis occurs as part of systemic vasculitis (microscopic polyangiitis, granulomatosis with polyangiitis, or eosinophilic granulomatosis with polyangiitis) with potential multiorgan involvement 1

• Rapidly progressive glomerulonephritis with acute kidney injury is the most common presentation, contrasting with the more indolent course typical of IgA nephropathy 5, 6

• 10-20% of cases are ANCA-negative but share identical histopathology and clinical behavior, though some studies suggest worse renal survival in seronegative cases 6

Critical Diagnostic Distinctions

Immunofluorescence Patterns (Pathognomonic)

• Lupus nephritis: Full-house pattern (IgG + IgA + IgM + C3 + C1q) in mesangial and capillary walls 1, 2

• IgA nephropathy: Mesangial-dominant or co-dominant IgA deposits 1, 2

• ANCA-associated GN: Negative or minimal (<1-2+) immunoglobulin staining 1, 2

Serologic Profiles

• Lupus nephritis: Positive ANA, anti-dsDNA, low C3/C4 1, 2

• IgA nephropathy: Normal complement levels, no specific autoantibodies 3

• ANCA-associated GN: Positive MPO-ANCA or PR3-ANCA in 80-90% of cases, normal complement 1, 2

Electron Microscopy Findings

• Lupus nephritis: Subendothelial, mesangial, and/or subepithelial electron-dense deposits 1, 2

• IgA nephropathy: Mesangial electron-dense deposits 1

• ANCA-associated GN: Absence of electron-dense deposits 2

Overlap Syndromes and Diagnostic Pitfalls

• Approximately 25% of anti-GBM disease patients also have circulating ANCA, creating a dual-positive syndrome that requires recognition of both pathogenic mechanisms 1, 2

• ANCA-positive lupus nephritis occurs in a subset of SLE patients and is associated with worse baseline renal function and lower proteinuria remission rates compared to ANCA-negative lupus nephritis 7

• Pauci-immune glomerulonephritis can rarely occur in SLE without ANCA positivity, representing a distinct pathophysiologic variant requiring different therapeutic considerations 8

• Segmental IgM and C3 staining in areas of segmental sclerosis is a nonspecific trapping phenomenon and should not be misinterpreted as true immune complex deposition 1, 2

• Lupus with predominantly IgA deposits has been reported but is rare; these cases often follow a more indolent course than typical lupus nephritis but can still progress to renal failure when crescentic glomerulonephritis develops 9